SynthesisHIV medicine2026

Outcomes of real-world initiation of long-acting injectable cabotegravir and rilpivirine (LA-I CAB + RPV) in individuals with viraemia: A systematic review of baseline characteristics, virological failure outcomes and discontinuations.

Alexa Elias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.